Feryal KARACA, Selahattin MENTES, Sıddık KESKİN

Evaluation of hematologic and biochemical parameters in patients with early stage uterine malignancy receiving radiotherapy

Surgery is the primary choice of treatment for this disorder. Radiotherapy is an important step of treatment in this cancer after surgery due to the stage of the disease. Lack of prospective randomised data for survival limits the use of adjuvant radiotherapy. Hovewer adjuvant radiotherapy is suggested for high risk patients to reduce locoregional recurrence. The aim of this study is to define the statistical difference of hemogram, transaminases, kidney function tests and electrolyte changes in patients before starting radiotherapy, the end of radiotherapy, with the onset of acute side effects, and three months after finishing radiotherapy with the onset of chronic side effects. 18 patients with early stage endometrial malignancy attending to Adana Numune Training and Research Hospital have been included. This study has assessed the changes in hemogram, blood transaminases, urea, creatinin and electrolyte values of patients before radiotherapy, at the last week of radiotherapy and three months after radiotherapy. The values were statistically significant for AST, Ca, LDH, urea, Hb and HTC values before treatment, at the end of the treatment and three months after treatment (p

PDF

___

Karsten M, Margrit V, Richard VG. Hemoglobin levels during radiation therapy and their influence on local control and survival of patients with endometrial carcinoma. Oncol Rep 2004; 11: 711- 717.

Dische S. Radiotherapy and anaemia--the clinical experience. Radiother Oncol 1991; 20: 35-40.

Demetri GD, Kris M, Wade J, et al. Quality-oflife benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit study group. J Clin Oncol 1998; 16: 3412-3425.

Cella D. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 1998; 25: 43-46.

Vuthinun Achariyapota, Mongkol Benjapibal, Pattama Chaopotong. Prevalence and Incidence of Anemia in Thai Patients with Gynecologic Cancer. Asian Pacific J Cancer Prev 11: 1229- 1233.

Agata Jodda, Bartosz Urban´ ski, Tomasz Piotrowski, Julian Malicki. Relations between doses cumulated in bone marrow and dose delivery techniques during radiation therapy of cervical and endometrial cancer. Physica Medica 2017; 36: 54-59.

F.A. Eggink, C.H.Mom, D. Boll, et al. Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients. Gynecologic Oncology 2017; 146: 380-385.

Kayaalp O, Rasyonel Tedavi Yönünden Tıbbi Farmakoloji, sayfa 1522-1524, 2.cilt, 8.Basım, Hacettepe Taş Kitapçılık, Sıhhıye, Ankara.

Leonard L. Gunderson, Joel E. Tepper. clınıcal radıatıon oncology. Fourth edıtıon. 1600 John F. Kennedy Blvd. Ste 1800 Philadelphia, PA 19103- 2899.

William H. McBride, H. Rodney Withers. Cancer Biology. Ed: Carlos A.Perez, Luther W.Brady, Edward C.Halperin, Rupert K.Schmidt-Ullrich. Principles and practice of radiation Oncology. 4th Edition, pp. 96-136, USA 2004.

Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 2001; 18: 243-259.

Barrett-Lee P, Bokemeyer C, Gascón P, et al Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from theEuropean Cancer Anemia Survey. Oncologist 2005; 10: 743-757.

Newman A, Katsaris J, Blendis LM, et al. Small intestinal injury in women who have had pelvic radiotherapy. Lancet 1973; 2: 1471-1473.

Bloomer WD, Hellman S. Normal tissue responses to radiation therapy. N Engl J Med 1975; 293: 80-83.

Klopp A, Smith BD, Alektiar K, et al. The role of postoperative radiation therapy for endometrial cancer: executive summary of an AmericanSociety for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2014; 4: 137-144.

Edward C. Halperin, Carlos A. Perez, Luther W. Brady. Principles and Practice of Radiation Oncology 5. basım. Lippincott Williams & Wilkins, a Wolters Kluwer business 530 Walnut Street Philadelphia, PA 19106 USA 2008.

Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K, Herzog TJ. Contemporary management of endometrial cancer. Lancet 2012; 379: 1352-1360.

Uterine neoplasms. NCCN Clinical Practice Guidelines in Oncology. Available at: uterine. pdf (accessed on 12/18/2016).

F.A. Tavassoli, P. Devilee (Eds.), World Health Organization classification of tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs, IARC Press, Lyon 2003.

V.M. Abeler, O. Røyne, S. Thoresen, H.E. Danielsen, J.M. Nesland, G.B. Kristensen, Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients, Histopathology 2009; 355-364.

Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980; 56: 419-427.

Sorbe B, Horvath G, Andersson H, Boman K, Lundgren C, Pettersson B. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma–a prospective randomized study. Int J Radiat Oncol Biol Phys 2012; 82: 1249-1255.

Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an openlabel, non-inferiority, randomised trial. Lancet 2010; 375: 816-823.

Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92: 744-751.

Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000; 355: 1404-1411.

W.T. Creasman, F. Odicino, P.Maisonneuve, M.A. Quinn, U. Beller, J.L. Benedet, A.P.M. Heintz, H.Y.S. Ngan, S. Pecorelli, Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer, Int. J. Gynaecol. Obstet. 95 (Suppl. 1) 2006; 105-143.

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403.

L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-tieulent, A. Jemal, Global cancer statistics, 2012, CA Cancer J. Clin 2015; 65: 87-108.

R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2015, CA Cancer J. Clin 2015; 65: 5-29.